Adiponectin deficiency makes a substantive contribution to the development of NAFLD and NASH in ob/ob mice, and hepatic structure and function are largely restored by adiponectin treatment [4]. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.